GSK is seeking an experienced Senior Director to provide scientific leadership for its hepatology portfolio within the Translational Biology Unit of the Respiratory, Immunology and Inflammation Research Unit. This is a senior individual-contributor role reporting to the Head of Hepatology Translational Biology. The role calls for deep expertise in preclinical biology and forward and reverse translation in liver disease, with responsibility for shaping strategy and advancing programmes in MASH, ALD, and related cardiometabolic comorbidities, including cardiovascular disease and obesity. The Senior Director will connect human disease biology with target science, biomarkers, and clinical development, ensuring preclinical evidence is relevant to human disease and helping de-risk translation into the clinic. The role offers influence across a diverse portfolio of clinical-stage programmes, preclinical projects, and target identification. As a key leader in the Hepatology Disease Area Acceleration Team, the successful candidate will help align patient biology, target hypotheses, translational strategies, biomarkers, and clinical endpoints across discovery and development. The position also involves shaping academic collaborations and providing scientific leadership for business development opportunities. The role is hybrid under GSK’s Performance with Choice programme. For candidates based at Stevenage, the role will initially be located there, with a planned relocation to Cambridge, UK, proposed by early 2029. Reasonable, purposeful travel is expected, including scientific conferences and occasional international collaboration meetings.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Senior
Education Level
Ph.D. or professional degree